ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00733863
Recruitment Status : Completed
First Posted : August 13, 2008
Last Update Posted : May 12, 2010
Sponsor:
Information provided by:
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2010
  Study Completion Date : No date given